Medifast
MED
236 hedge funds and large institutions have $892M invested in Medifast in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 80 reducing their positions, and 62 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 80
4.99% less ownership
Funds ownership: 93.78% → 88.79% (-5%)
12% less funds holding
Funds holding: 267 → 236 (-31)
16% less capital invested
Capital invested by funds: $1.06B → $892M (-$170M)
50% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 62
64% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $30.3M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$13.4M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.5M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.43M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.71M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$23.2M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$14M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$11.8M |
| 4 |
2L
22NW LP
Seattle,
Washington
|
-$9.29M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$7.78M |
MED Hedge Fund Activity: Q2 2023 in Review
236 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2023, worth a combined $892M — down 16% from $1.06B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of MED and 31 opened new positions — a net loss of 31 holders — while 80 trimmed existing stakes and 88 added.
The largest buyer was Man Group, opening a new position worth an estimated $13.4M. The largest seller was Millennium Management, cutting an estimated $23.2M.
- 236 institutional investors held Medifast (MED) as of Q2 2023, down from 267 in Q1 2023.
- Funds reported $892M of Medifast stock for Q2 2023, down 16% quarter-over-quarter.
- 31 funds opened new Medifast positions in Q2 2023 and 62 closed out, a net change of -31 holders.
- The largest Medifast buyer in Q2 2023 was Man Group, an estimated $13.4M added.
- The largest Medifast seller in Q2 2023 was Millennium Management, an estimated $23.2M sold.
Based on aggregated 13F filings for Q2 2023.